Research
10.11.2021

ÖGP 2021: Meta-analysis on the specificity of microbiome-based signatures for predicting immune checkpoint inhibitor therapy response in non-small cell lung cancer patients

ready to TALK MICROBIOME?
Reach out to our team with any questions about BiomeDx. We're here to support your understanding of our platform and services.
Arrow right icon
z
z
z
z
i
i
z
z
Let’s build the future of
preventive health.
Bring AI-powered microbiome insights to your customers.
Join our global network of laboratories, clinics, and research centres.